Xenon Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Xenon Pharmaceuticals patents 45 in total
Status | Patent |
---|---|
Application | Utility: METHODS AND USES FOR TREATING ANHEDONIA Filling date: 6 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: METHODS FOR TREATING ABSENCE SEIZURES Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Benzenesulfonamide compounds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Benzenesulfonamide compounds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: Substituted benzamides and methods of use thereof Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Benzenesulfonamide compouds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 16 Nov 2021 |
Grant | Utility: Therapeutic compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener Filling date: 6 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Therapeutic compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 28 Sep 2021 |
Application | Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 19 Aug 2021 |
Grant | Utility: Solid state crystalline forms of a selective potassium channel modulator Filling date: 6 Sep 2025 Issue date: 17 Aug 2021 |
Application | Utility: METHODS OF TREATING PAIN Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OPENER EZOGABINE Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: METHODS OF TREATING DEPRESSIVE DISORDERS Filling date: 6 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR Filling date: 6 Sep 2025 Issue date: 20 May 2021 |
Grant | Utility: Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Substituted benzamides useful as sodium channel blockers Filling date: 6 Sep 2025 Issue date: 26 Jan 2021 |
Application | Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Filling date: 6 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Benzenesulfonamide compounds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Therapeutic compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Substituted benzamides and methods of use thereof Filling date: 6 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Benzenesulfonamide compounds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 18 Aug 2020 |
Grant | Utility: Benzenesulfonamide compounds and their use as therapeutic agents Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Application | Utility: HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Filling date: 6 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: SOLID STATE FORMS OF SPIRO-OXINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS SODIUM CHANNEL INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHOD FOR TREATING EPILEPSY Filling date: 6 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: Therapeutic compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 7 Jan 2020 |
Grant | Utility: Solid state forms of spiro-oxindole compounds Filling date: 6 Sep 2025 Issue date: 24 Dec 2019 |
Application | Utility: BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER Filling date: 6 Sep 2025 Issue date: 14 Nov 2019 |
Grant | Utility: Therapeutic compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 29 Oct 2019 |
Showing 1 to 45 of 45 patents.